EU Clinical Trials Register

Size: px
Start display at page:

Download "EU Clinical Trials Register"

Transcription

1 EU Clinical Trials Register Sponsor Contact Information Abbott Laboratories Ltd Abbott House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire SL6 4XE UK Telephone number Ablynx NV Ablynx NV Technologiepark 21 B-9052 Zwijnaarde Belgium Telephone number Actelion Pharmaceuticals Ltd (Global Medical Information) Actelion Pharmaceuticals Ltd. Gewerbestrasse 3 CH-4123 Allschwil Active Biotech AB PO Box 724, Scheelevägen 22, SE Lund, Sweden Telephone Number Amgen Medical Information Amgen (EUROPE) GmbH Dammstrasse 23 P.O. Box 1557 (not on the website) (CH-)6300 Zug Astellas Global Development Operations Elisabethhof EW Leiderdorp Telephone Number Page - 1

2 AstraZeneca AB Austrian Breast & Colorectal Cancer Study Group (ABCSG) Nussdorfer Platz 8 / , A-1190 Wien Telephone number Fax number Bayer HealthCare AG Bayer Clinical Trials Contact CTP Team / Ref: "EU CTR" Bayer Pharma AG, S102, Level 2, Room Berlin Contact phone number: BIAL Portela & Cª, SA Section of Clinical Research and Drug Safety Management À Avenida da Siderurgia Nacional S. Mamede do Coronado Portugal Telephone Number BioAlliance Pharma 49 boulevard du Général Martial Valin Paris, France Telephone number Biogen Idec Ltd Innovation House, 70 Norden Road Maidenhead, Berkshire, UK. SL6 4AY Boehringer Ingelheim Boehringer Ingelheim Pharma GmbH & Co. KG QRPE Processes and Systems Coordination Clinical Trial Information Disclosure Binger Strasee Ingelheim am Rhein Telephone number

3 Bristol-Myers Squibb International Corporation BMS- EU StartUp Department Attn: Dept Manager Parc de l'alliance, Avenue de Finlande, Braine l'alleud Belgium Celgene Corporation Corporate Woods Bldg. 70, Suite W. 109th Street Overland Park, Kansas U.S.A. International toll-free telephone number EISAI European Medical Information Eisai Europe Limited European Knowledge Centre, Mosquito Way Hatfield Herts AL10 9SN Telephone number Telephone number Fax number Eli Lilly and Company Eli Lilly and Company Limited Lilly S.A. EORTC European Organisation for Research and Treatment of Cancer AISBL-IVZW Avenue E. Mounierlaan, 83/11 Bruxelles 1200 Brussel Belgique - Belgïe Telephone Number +32 (0) ERYtech Pharma Batiment Adénine 60 Avenue Rockefeller LYON - FRANCE Telephone Number

4 Genmab A/S Bredgade 34, 1260 Copenhagen K, Denmark Telephone Number Genzyme Europe BV Gooimeer 10, 1411 DD Naarden, The Netherlands GlaxoSmithKline GlaxoSmithKline, Iron Bridge Road, Stockley Park West, Uxbridge, Middlesex, UB11 1BU, UK Telephone number I.R.I.S Institut de Recherches Internationales Servier International and Pre-Submission Division, Clinical Studies Department 6, place des Pleiades Courbevoie Cedex France Telephone number MedImmune Limited One MedImmune Way Gaithersburg, MD Telephone number Menarini Ricerche S.p.A. Via Sette Santi, Florence, (FI) Italy Telephone number Merck KGaA or Merck Serono S.A. Geneva Merck Merck KGaA Frankfurter Strasse Darmstadt Telephone number

5 Merck Sharp and Dohme Corp 126 E. Lincoln Avenue RY34-A100 Rahway, NJ USA Telephone number Merz Pharmaceuticals GmbH Global Clinical Development Operations Eckenheimer Landstrasse Frankfurt Norpharma A/S Medical Manager Slotsmarken 15, DK-2970 Hoersholm, Denmark Telephone number Novartis Pharma AG Forum 1, Novartis Campus 4056 Basel, Telephone number Novo Nordisk A/S Global Clinical Registry (GCR,1452) Vandtaarnsvej 114, VTB DK-2860 Soeborg Denmark Orion Corporation Tengstöminkatu 8, P.O.Box 425; FI Turku Finland Telephone number Pfizer Inc 235 E 42 nd Street New York NY10017, USA Telephone Number Fax Number

6 PharmaMar Avda. De los Reyes 1 Pol. Ind. La Mina Colmenar Viejo (Madrid) Spain Telephone number Phytopharm plc Lakeview House 2 Lakeview Court Ermine Business Park Huntingdon PE29 6UA Telephone number F. Hoffmann-La Roche Ltd. Trial Information Support Line-TISL Grenzacherstrasse , Basel Genentech Inc. C/O F. Hoffmann-La Roche Ltd. Trial Information Support Line-TISL Grenzacherstrasse , Basel Sanofi-aventis Trial Transparency Team (CSO-SCP - Clinical Documentation) Telephone Number (BWX/USA) TiGenix n.v. Romeinse Straat 12/2, B-3001 Leuven, Belgium Telephone Number Vectura Group Plc 1 Prospect West Chippenham SN14 6FH Telephone Number

7 Vifor Pharma Ltd Global Medical Information Flughofstr. 61 P.O. Box CH-8152 Glattbrugg Telephone number Fax number

Outcomes of Monitoring Committee Reviews. Medicines Australia Code of Conduct

Outcomes of Monitoring Committee Reviews. Medicines Australia Code of Conduct Outcomes of Monitoring Committee Reviews Medicines Australia Code of Conduct 1 Medicines Australia ABN 23 126 990 001 Level 1, 16 Napier Close Deakin ACT 2600 Phone: 02 6122 8500 Fax: 02 6122 8555 Web:

More information

Pharma working capital performance highly variable

Pharma working capital performance highly variable April 2014 Pharma working capital performance highly variable 41 Billion in Excess Working Capital We last completed this survey in 2012. We expected that there would be a broad improvement across the

More information

The Hong Kong Association of The Pharmaceutical Industry

The Hong Kong Association of The Pharmaceutical Industry The Hong Kong Association of The Pharmaceutical Industry UNIT A, 20/F., TIMES MEDIA CENTRE, FAX: (852) 2865 6283 WEBSITE: www. hkapi.hk Position Paper on the Pharmacy and Poisons (Amendment) Bill 2014

More information

Small-Cell Lung Cancer Global Clinical Trials Review, H2, 2015

Small-Cell Lung Cancer Global Clinical Trials Review, H2, 2015 Brochure More information from http://www.researchandmarkets.com/reports/3398017/ Small-Cell Lung Cancer Global Clinical Trials Review, H2, 2015 Description: Small-Cell Lung Cancer Global Clinical Trials

More information

European Biotech & Pharma Dr. Patrik Frei May 2014 Tokyo

European Biotech & Pharma Dr. Patrik Frei May 2014 Tokyo European Biotech & Pharma Dr. Patrik Frei May 2014 Tokyo 1 Overview 1. Venture Valuation 2. Trends in the EU Biotech & Pharma 3. Overview European Biotechs / Clusters 2 Valuation Valuation Mission Independent

More information

The Global Biotech Industry: Challenges & Opportunities Michael S. Rosen Rosen Bioscience Strategies

The Global Biotech Industry: Challenges & Opportunities Michael S. Rosen Rosen Bioscience Strategies The Global Biotech Industry: Challenges & Opportunities Michael S. Rosen Rosen Bioscience Strategies Greetings from Chicago! Beaches Yes! Pharma Beginnings! Bogota 1974 Selling Drugs in Colombia Global

More information

Pharma working capital leaves room for improvement

Pharma working capital leaves room for improvement October 2012 Pharma working capital leaves room for improvement 50.7 Billion in Excess Working Capital Ten years ago it was not unusual to be asked why working capital mattered to a pharmaceutical company.

More information

Clinical trial research agreement Agreed schedule 4 or 7 clause amendments

Clinical trial research agreement Agreed schedule 4 or 7 clause amendments Clinical trial research agreement Agreed schedule 4 or 7 clause amendments Medicines Australia and Medical Technology Association of Australia templates The sponsors in the table have agreed clauses for

More information

Rx-360 An International Pharmaceutical Supply Chain Consortium

Rx-360 An International Pharmaceutical Supply Chain Consortium Rx-360 An International Pharmaceutical Supply Chain Consortium Overview Rx-360 and the Audit Sharing Program September 2011 Rx-360 Members (Continuously updated list at www.rx-360.org) Manufacturers (24)

More information

KEEPING CLINICAL TRIALS IN AUSTRALIA

KEEPING CLINICAL TRIALS IN AUSTRALIA OCCASIONAL PAPER SERIES KEEPING CLINICAL TRIALS IN AUSTRALIA WHY ACTION IS NEEDED NOW OCCASIONAL PAPER SERIES > Medicines Australia is producing Occasional Papers to promote a contest of ideas, thought

More information

M&A und Allianzen in Life Science Aktuelle Entwicklungen und Trends

M&A und Allianzen in Life Science Aktuelle Entwicklungen und Trends M&A und Allianzen in Life Science Aktuelle Entwicklungen und Trends Symposium Life Science am Kapitalmarkt Frankfurt, 3. Juni 28 Global biotech industry Strong growth in most areas but Visible product

More information

CHEM-E4140 Selectivity 12. Pharma Business

CHEM-E4140 Selectivity 12. Pharma Business CHEM-E4140 Selectivity 12. Pharma Business Prof. Ari Koskinen Laboratory of Organic Chemistry C318 Pharma Business Total volume ca 1100 G$ (Shell 421G$; Walmart 486G$; Toyota 252 G$). Annually approx 25

More information

Malignant Mesothelioma - Pipeline Review, H1 2015

Malignant Mesothelioma - Pipeline Review, H1 2015 Brochure More information from http://www.researchandmarkets.com/reports/3308784/ Malignant Mesothelioma - Pipeline Review, H1 2015 Description: Malignant Mesothelioma - Pipeline Review, H1 2015 Summary

More information

CODE FOR DISCLOSURE OF TRANSFERS OF VALUE BY PHARMACEUTICAL COMPANIES TO HEALTHCARE PROFESSIONALS AND HEALTH ORGANIZATIONS

CODE FOR DISCLOSURE OF TRANSFERS OF VALUE BY PHARMACEUTICAL COMPANIES TO HEALTHCARE PROFESSIONALS AND HEALTH ORGANIZATIONS CODE FOR DISCLOSURE OF TRANSFERS OF VALUE BY PHARMACEUTICAL COMPANIES TO HEALTHCARE PROFESSIONALS AND HEALTH ORGANIZATIONS Adopted November 2013, in force since 1 st of January 2014. INTRODUCTION The Association

More information

Metastatic Breast Cancer - Pipeline Review, Q1 2011

Metastatic Breast Cancer - Pipeline Review, Q1 2011 Brochure More information from http://www.researchandmarkets.com/reports/1524592/ Metastatic Breast Cancer - Pipeline Review, Q1 2011 Description: Metastatic Breast Cancer - Pipeline Review, Q1 2011 Summary

More information

Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Market (Competitor Focus)

Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Market (Competitor Focus) A Datamonitor report Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Market (Competitor Focus) Published: Oct 07 Product Code: DMTC2133 Providing you with: Identifies which technology vendors

More information

ehealthinsight Series: Online Patient Recruitment Strategies

ehealthinsight Series: Online Patient Recruitment Strategies A Datamonitor report ehealthinsight Series: Online Patient Recruitment Strategies Published: May-08 Product Code: Providing you with: Overview of benefits and drawbacks of online Analysis of online patient

More information

Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019

Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019 Brochure More information from http://www.researchandmarkets.com/reports/3453273/ Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019 Description: About non-small cell lung cancer therapeutics

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 21 October 2015 EMA/827738/2015 Procedure Management and Committees Support Active substance: ondansetron Procedure no.: PSUSA/00002217/201502 30 Churchill Place Canary Wharf London E14 5EU United Kingdom

More information

EFPIA Position Paper on REACH. Executive Summary. Position Paper. Draft Final. Author: EFPIA Date: October 2015 Version: Final

EFPIA Position Paper on REACH. Executive Summary. Position Paper. Draft Final. Author: EFPIA Date: October 2015 Version: Final Draft Final EFPIA Position Paper on REACH Author: EFPIA Date: October 2015 Version: Final Position Paper Executive Summary An increasing number of substances used in the pharmaceutical manufacturing process

More information

Pertuzumab in Trastuzumab- Treated, Advanced HER2-Positive Breast Cancer

Pertuzumab in Trastuzumab- Treated, Advanced HER2-Positive Breast Cancer Pertuzumab in Trastuzumab- Treated, Advanced HER2-Positive Breast Cancer For more visit ResearchToPractice.com/5MJC CME INFORMATION OVERVIEW OF ACTIVITY Each year, thousands of clinicians and basic scientists

More information

In the largest and perhaps the most ambitious collaborative

In the largest and perhaps the most ambitious collaborative FEATURES THE BIRTH OF TRANSCELERATE BIOPHARMA, INC. Revolution in Clinical Research Partnerships by Dalvir Gill and Garry Neil In the largest and perhaps the most ambitious collaborative effort ever initiated

More information

The World's Top 100 Pharmaceutical Companies

The World's Top 100 Pharmaceutical Companies Brochure More information from http://www.researchandmarkets.com/reports/1878687/ The World's Top 100 Pharmaceutical Companies Description: Did you know? - Dr. Jeremy Levin is Senior Vice President, Strategy,

More information

Global Pharmaceuticals Marketing Channel Reference EDITION

Global Pharmaceuticals Marketing Channel Reference EDITION Global Pharmaceuticals Marketing Channel Reference EDITION 2015 ABOUT IMS HEALTH IMS Health is a leading global information and technology services company providing clients in the healthcare industry

More information

Oracle Buys Phase Forward Expands Oracle s solutions for the life sciences and healthcare industries

Oracle Buys Phase Forward Expands Oracle s solutions for the life sciences and healthcare industries Oracle Buys Phase Forward Expands Oracle s solutions for the life sciences and healthcare industries April 16, 2010 Oracle is currently reviewing the existing Phase Forward product roadmap and will be

More information

The United States False Claims Act Qui Tam Whistleblower Law

The United States False Claims Act Qui Tam Whistleblower Law The United States False Claims Act Qui Tam Whistleblower Law Getnick & Getnick LLP Counsellors At Law Rockefeller Center, 620 Fifth Avenue New York, NY 10020 Phone: (212) 376-5666 Fax: (212) 292 3942 www.getnicklaw.com

More information

The Importance of the Pharmaceutical Industry for Switzerland

The Importance of the Pharmaceutical Industry for Switzerland Study on behalf of Interpharma The Importance of the Pharmaceutical Industry for Switzerland BAK Basel Economics Michael Grass, Samuel Mösle In collaboration with Polynomics Published by: Interpharma,

More information

C h a r t 1 - KPNQwest Group

C h a r t 1 - KPNQwest Group C h a r t 1 - Group NV BIJLAGE / ANNEX 1 IP Services BV Services Finance BV financing moratorium: 30-05 bankruptcy: 25-09 09-2002 Assets Central Europe BV moratorium: 18-06 moratorium has ended Netherlands

More information

Global R&D spending survey 2002-2004

Global R&D spending survey 2002-2004 Global R&D spending survey 2002-2004 Cientifica has surveyed the top 100 global corporate spenders in research and development over the last three years. Data was obtained from annual reports and encompasses

More information

VAB REPORT: ITS TIME FOR A CHECK UP! UPDATE ON THE HEALTHCARE INDUSTRY

VAB REPORT: ITS TIME FOR A CHECK UP! UPDATE ON THE HEALTHCARE INDUSTRY VAB REPORT: ITS TIME FOR A CHECK UP! UPDATE ON THE HEALTHCARE INDUSTRY SUMMARY Healthcare Summary Personal health care expenditures projected to grow 26% in the next 4 years Hospital care sector comprises

More information

Pivot Park Screening Centre participates in novel 196 million pan-european drug discovery platform

Pivot Park Screening Centre participates in novel 196 million pan-european drug discovery platform PRESS RELEASE Pivot Park Screening Centre participates in novel 196 million pan-european drug discovery platform Pivot Park Screening Centre in Oss will play an important role in a new pan-european drug

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 13 May 2016 EMA/364968/2016 Procedure Management and Committees Support Active substance: desogestrel / ethinylestradiol Procedure no.: PSUSA/00000967/201509 30 Churchill Place Canary Wharf London E14

More information

Stakeholder Perspectives: Mild Cognitive Impairment and Dementia

Stakeholder Perspectives: Mild Cognitive Impairment and Dementia A Datamonitor In-Depth Analysis Stakeholder Perspectives: Mild Cognitive Impairment and Dementia Aricept in Race to Pioneer Unexplored Markets Published: Aug-03 Product Code: DMHC1924 Why buy this analysis?

More information

The Pharmaceutical Industry in Figures

The Pharmaceutical Industry in Figures The Pharmaceutical Industry in Figures Key Data 2014 THE PHARMACEUTICAL INDUSTRY: A KEY ASSET TO SCIENTIFIC AND MEDICAL PROGRESS Thanks to advances in science and technology, the researchbased pharmaceutical

More information

The Pharmaceutical Industry in Figures

The Pharmaceutical Industry in Figures The Pharmaceutical Industry in Figures Key Data 2015 THE PHARMACEUTICAL INDUSTRY: A KEY ASSET TO SCIENTIFIC AND MEDICAL PROGRESS Thanks to advances in science and technology, the researchbased pharmaceutical

More information

Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2015

Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2015 Brochure More information from http://www.researchandmarkets.com/reports/3293079/ Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2015 Description: Relapsing Remitting Multiple Sclerosis

More information

DRUGS FOR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS: GLOBAL MARKETS

DRUGS FOR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS: GLOBAL MARKETS DRUGS FOR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS: GLOBAL MARKETS PHM159A March 2014 Sanjukta Bhattacharyya Project Analyst ISBN: 1-56965-754-8 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481

More information

PRAC recommendations on signals

PRAC recommendations on signals 25 June 2015 EMA/PRAC/383371/2015 Pharmacovigilance Risk Assessment Committee Adopted at the PRAC meeting of 8-11 June 2015 This document provides an overview of the recommendations adopted by the Pharmacovigilance

More information

OFFICE OF ATTORNEY GENERAL LAWRENCE G. WASDEN AVERAGE WHOLESALE PRICE LITIGATION REPORT AUGUST 2013

OFFICE OF ATTORNEY GENERAL LAWRENCE G. WASDEN AVERAGE WHOLESALE PRICE LITIGATION REPORT AUGUST 2013 Introduction OFFICE OF ATTORNEY GENERAL LAWRENCE G. WASDEN AVERAGE WHOLESALE PRICE LITIGATION REPORT AUGUST 2013 In 2007, Attorney General Wasden filed lawsuits against 33 pharmaceutical companies for

More information

Total Compensation Measurement. Global TCM Participants. Turkey

Total Compensation Measurement. Global TCM Participants. Turkey Total Compensation Measurement 2008 Global TCM Participants Turkey Turkey 2008 TCM Participants Summary Information The table below lists key summary information on the 67 TCM participants for 2008. Measure

More information

Malignant Pleural Mesothelioma - Pipeline Review, H2 2014

Malignant Pleural Mesothelioma - Pipeline Review, H2 2014 Brochure More information from http://www.researchandmarkets.com/reports/2904677/ Malignant Pleural Mesothelioma - Pipeline Review, H2 2014 Description: Malignant Pleural Mesothelioma - Pipeline Review,

More information

The Role Of Industry in the Australian Clinical Trials Sector

The Role Of Industry in the Australian Clinical Trials Sector Mitch Kirkman, Development QA Manager Australian Clinical Trials Alliance Symposium 09 October 2015 CORP0270 September 2015 Global Clinical Development Local Clinical Trials Australian Medical Research

More information

Multiple Sclerosis Therapeutics to 2019 - Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine to Drive Growth

Multiple Sclerosis Therapeutics to 2019 - Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine to Drive Growth Brochure More information from http://www.researchandmarkets.com/reports/2640803/ Multiple Sclerosis Therapeutics to 2019 - Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine

More information

6 th Proactive GCP Compliance Effective Risk- Based Approaches for Optimizing Clinical Quality

6 th Proactive GCP Compliance Effective Risk- Based Approaches for Optimizing Clinical Quality 6 th Proactive GCP Compliance Effective Risk- Based Approaches for Optimizing Clinical Quality March 24-25, 2015 Wyndham Philadelphia Historic District, Philadelphia, PA www.exlevents.com/gcp Sponsors

More information

A survey conducted by: The Swedish Drug Development Pipeline May 2011

A survey conducted by: The Swedish Drug Development Pipeline May 2011 A survey conducted by: The Swedish Drug Development Pipeline May 2011 The survey In February March 2011 a survey of the Swedish Drug Development Pipeline was conducted by SwedenBIO in cooperation with

More information

Pharma RepTrak 2015 The World s Most Reputable Pharmaceutical Companies

Pharma RepTrak 2015 The World s Most Reputable Pharmaceutical Companies Pharma RepTrak 2015 The World s Most Reputable Pharmaceutical Companies The Pharma Industry s Reputation in the Eyes of the General Public A Reputation Study with Consumers in 15 Countries RepTrak is a

More information

VEDLEGG I. Liste Over Navn, Legemiddelformer, Legemiddelstyrker, Administrasjonsmåte, Innehavere Av Markedsføringstillatelsen I Medlemslandene

VEDLEGG I. Liste Over Navn, Legemiddelformer, Legemiddelstyrker, Administrasjonsmåte, Innehavere Av Markedsføringstillatelsen I Medlemslandene VEDLEGG I Liste Over, Leemiddelformer, Leemiddelstyrker, Administrasjonsmåte, Innehavere Av Markedsførinstillatelsen I Medlemslandene 1 Østerrike Belia Belia Bularia Kypros Kypros Pfizer Corporation Austria

More information

Life Sciences Financing Summary Europe December 2014

Life Sciences Financing Summary Europe December 2014 Europe December 2014 In stark contrast to their summer inactivity, private Biotech European companies (Therapeutics & Diagnostics) raised the highest equity financing amount of the year in September with

More information

Manufacturer of drug substance

Manufacturer of drug substance Original s and Biosimilars (marketing authorizations in the EU) Date: January 2016 1) Somatropin s ORIGINAL PRODUCTS: Authorization Genentech Genotropin Somatropin Pharmacia/ Pfizer E. coli Humatrope Somatropin

More information

Pharmaceutical Marketing Disclosures

Pharmaceutical Marketing Disclosures Pharmaceutical Marketing Disclosures July 1, 2007 June 30, 2008 Report of Vermont Attorney General William H. Sorrell April 2009 Prepared by staff of the Vermont Attorney General s Office: Wendy Morgan,

More information

Egy magyar, nagynyomású hidrogén-generátor Perspektívák és alkalmazások idehaza és külföldön

Egy magyar, nagynyomású hidrogén-generátor Perspektívák és alkalmazások idehaza és külföldön Egy magyar, nagynyomású hidrogén-generátor Perspektívák és alkalmazások idehaza és külföldön Dr. Darvas Ferenc Dr. Remzsı Tibor ThalesNano Zrt. (Budapest), ThalesNano LLC (Princeton, NJ, USA) Main Tech

More information

The Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals

The Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals The Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals Michelle Gittelman Department of Business and Management Rutgers Business School Newark-New Brunswick, New Jersey The pharmaceutical

More information

December 17, 2014 HOW PHARMA MARKETERS FIND AND SELECT DIGITAL MARKETING AGENCIES

December 17, 2014 HOW PHARMA MARKETERS FIND AND SELECT DIGITAL MARKETING AGENCIES December 17, 2014 HOW PHARMA MARKETERS FIND AND SELECT DIGITAL MARKETING AGENCIES by Dennis van Rooij with Tim van Tongeren EXECUTIVE SUMMARY More than half of pharma marketers don t or can t leverage

More information

Funderingar om etik i medicinsk forskning. Hálfdán Pétursson PhD Forskare och ST-läkare

Funderingar om etik i medicinsk forskning. Hálfdán Pétursson PhD Forskare och ST-läkare Funderingar om etik i medicinsk forskning Hálfdán Pétursson PhD Forskare och ST-läkare Etik i medicinsk forskning I. Ärlighet II. Mänskliga rättigheter och grundläggande medicinsk etik III. Metodik IV.Den

More information

Serialization Technology - Seidenader: Integral Solution Provider

Serialization Technology - Seidenader: Integral Solution Provider Serialization Technology - Seidenader: Integral Solution Provider Sindusfarma August, 28th 2013 Dr. Stefan Loelkes Agenda 1 2 Your challenge Company overview 3 4 Integral solution provider Products 2 Your

More information

Commercial Insight Osteoarthritis and Rheumatoid Arthritis

Commercial Insight Osteoarthritis and Rheumatoid Arthritis A Datamonitor In-Depth Analysis Commercial Insight Osteoarthritis and Rheumatoid Arthritis New Growth In A Mature Market Published: Jul-03 Product Code: DMHC1891 Why buy this analysis? Target current and

More information

Blockbuster!!! Content Management in the Pharmaceutical Industry An Overview. Global Pharma Market Shares by Sales (Approx. USD 700 Billion) Global

Blockbuster!!! Content Management in the Pharmaceutical Industry An Overview. Global Pharma Market Shares by Sales (Approx. USD 700 Billion) Global Content Management in the Pharmaceutical Industry An Overview Blockbuster!!! Avatar USD 2 Billion revenues Lipitor USD 12.5 Billion in 2008 Dr Arun Gangatkar http://in.linkedin.com/in/drarungangatkar drarunj@gmail.com

More information

LuxeMbOurG Trading CenTre LisT Annex 1 to the s pecial terms and conditions for securities transactions Valid as from 1 January 2011

LuxeMbOurG Trading CenTre LisT Annex 1 to the s pecial terms and conditions for securities transactions Valid as from 1 January 2011 Luxembourg Annex 1 to the Special terms and conditions for securities transactions Valid as from 1 January 2011 In order to achieve the best possible result in executing security orders, the bank has selected

More information

UniFlux 10: hollow fiber conversion kit (03-0089-67) installation instruction

UniFlux 10: hollow fiber conversion kit (03-0089-67) installation instruction GE Healthcare Instruction 28-9052-35 AA UniFlux 10: hollow fiber conversion kit (03-0089-67) installation instruction Important! Before commencing with the installation, carefully read through this document.

More information

Key Findings. Use this report to... The Autoimmune Market Outlook to 2013

Key Findings. Use this report to... The Autoimmune Market Outlook to 2013 Key Findings The global autoimmune market generated sales of $31.9bn in, an increase of 14.4% over 2006 sales. The market is forecast to grow at a CAGR of 8.1% to reach a total value of $51.0bn in 2013.

More information

Competence in Engineering & Contracting for the Pharmaceutical Industry

Competence in Engineering & Contracting for the Pharmaceutical Industry Competence in Engineering & Contracting for the Pharmaceutical Industry Postal address: Postfach 21 03 53 01265 Dresden, Germany House address: Bodenbacher Straße 80 01277 Dresden, Germany Linde-KCA-Dresden

More information

The Pharmaceutical Industry in Figures

The Pharmaceutical Industry in Figures The Pharmaceutical Industry in Figures Key Data 2013 THE PHARMACEUTICAL INDUSTRY: A KEY ASSET TO SCIENTIFIC AND MEDICAL PROGRESS Thanks to advances in science and technology, the researchbased pharmaceutical

More information

PRAC recommendations on signals

PRAC recommendations on signals 19 November 2015 EMA/PRAC/711550/2015 Pharmacovigilance Risk Assessment Committee (PRAC) Adopted at the PRAC meeting of 3-6 November 2015 This document provides an overview of the recommendations adopted

More information

Anti-CD20 Monoclonal Antibodies - Global Strategic Business Report

Anti-CD20 Monoclonal Antibodies - Global Strategic Business Report Brochure More information from http://www.researchandmarkets.com/reports/1382330/ Anti-CD20 Monoclonal Antibodies - Global Strategic Business Report Description: This report analyzes the Global market

More information

Trading in International Equities For Professional Advisers only - not to be relied upon by retail clients

Trading in International Equities For Professional Advisers only - not to be relied upon by retail clients Trading in International Equities For Professional Advisers only - not to be relied upon by retail clients 2 ALLIANCE TRUST SAVINGS About us We are part of the Alliance Trust group and have the backing

More information

Christopher Kratochvil, MD, Assistant Vice Chancellor for Clinical Research Deborah Vetter, MS, Director, Sponsored Programs Administration

Christopher Kratochvil, MD, Assistant Vice Chancellor for Clinical Research Deborah Vetter, MS, Director, Sponsored Programs Administration Christopher Kratochvil, MD, Assistant Vice Chancellor for Clinical Research Deborah Vetter, MS, Director, Sponsored Programs Administration Clinical Research Center Learn-At-Lunch Series October 13, 2011

More information

Rx-360Upstream Supply Chain Security A Supplier Collaborative Approach to Mitigate Risk and Enhance Transparency

Rx-360Upstream Supply Chain Security A Supplier Collaborative Approach to Mitigate Risk and Enhance Transparency Rx-360Upstream Supply Chain Security A Supplier Collaborative Approach to Mitigate Risk and Enhance Transparency www.rx-360.org www.rx-360.org Presenter: Rob Welsh, VWR International, LLC VP Category Management

More information

Stakeholder Insight: Insulin Use in Type 2 Diabetes

Stakeholder Insight: Insulin Use in Type 2 Diabetes A Datamonitor Report Stakeholder Insight: Insulin Use in Type 2 Diabetes From Last Resort to Early Intervention Published: May-04 Product Code: DMHC1989 Providing you with: Analysis of Datamonitor s Diabetes

More information

Fit for Health 2.0 - International Strategy Development Training Innovative Business Solutions and Smart Financing

Fit for Health 2.0 - International Strategy Development Training Innovative Business Solutions and Smart Financing Fit for Health 2.0 - International Strategy Development Training Innovative Business Solutions and Smart Financing Thursday 08 October 2015 8-9 October 2015, Copenhagen (Denmark) Medicon Valley Alliance,

More information

BOLT Hem/Onc Thought Leader Panel #38 Cancer Immunotherapy 2014-05

BOLT Hem/Onc Thought Leader Panel #38 Cancer Immunotherapy 2014-05 Syndicated Thought Leader Insight Healthcare & Pharmaceutical Research Cancer Immunotherapy Melanoma, Non- Small Cell Lung Cancer, Renal Cell Carcinoma Thought Leader Panel #38 2014-05 Therapeutic Area:

More information

Chapter 5. Using bibliometrics to inform cancer research policy and spending

Chapter 5. Using bibliometrics to inform cancer research policy and spending Chapter 5 Using bibliometrics to inform cancer research policy and spending Richard Sullivan, Seth Eckhouse and Grant Lewison for the European Cancer Research Managers Forum Richard Sullivan is chairman

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 10 September 2015 EMA/589993/2015 Procedure Management and Committees Support List of nationally authorised medicinal products Active substance: levonorgestrel Procedure No.: PSUSA/00001856/201412 30 Churchill

More information

Stakeholder Insight: Multiple Sclerosis Disease-modifying Efficacy and Side Effects Guide Treatment Choice

Stakeholder Insight: Multiple Sclerosis Disease-modifying Efficacy and Side Effects Guide Treatment Choice A Datamonitor report Stakeholder Insight: Multiple Sclerosis Disease-modifying Efficacy and Side Effects Guide Treatment Choice Published: Dec-06 Product Code: Providing you with: An overview of epidemiology,

More information

全 球 多 发 性 硬 化 症 治 疗 市 场 研 究 报 告 Multiple Sclerosis Therapeutics - A Global Strategic Business Report

全 球 多 发 性 硬 化 症 治 疗 市 场 研 究 报 告 Multiple Sclerosis Therapeutics - A Global Strategic Business Report /wepdwukltuyot 全 球 多 发 性 硬 化 症 治 疗 市 场 研 究 报 告 Multiple Sclerosis Therapeutics - A Global Strategic Business Report 联 系 购 买 电 话 :010-82863480 公 司 名 称 : 佐 思 信 息 公 司 地 址 : 北 京 市 海 淀 区 苏 州 街 18 号 院 长 远 天

More information

Global Monoclonal Antibodies Pipeline Insight 2015

Global Monoclonal Antibodies Pipeline Insight 2015 Brochure More information from http://www.researchandmarkets.com/reports/3113388/ Global Monoclonal Antibodies Pipeline Insight 2015 Description: Ever since the Nobel Prize was bestowed on the person who

More information

SAKK SEMI-ANNUAL MEETING

SAKK SEMI-ANNUAL MEETING SAKK SEMI-ANNUAL MEETING THURSDAY, JUNE 26, 2014 AND FRIDAY, JUNE 27, 2014 AT THE CONGRESS CENTER BERN EXPO MINGERSTRASSE 6, 3000 BERNE 22 SAKK COORDINATING CENTER EFFINGERSTRASSE 40 3008 BERNE T +41 31

More information

Top ICT spenders in the US Pharmaceutical Industry - Estimated ICT budget breakdowns in 2013

Top ICT spenders in the US Pharmaceutical Industry - Estimated ICT budget breakdowns in 2013 Brochure More information from http://www.researchandmarkets.com/reports/2599260/ Top ICT spenders in the US Pharmaceutical Industry - Estimated ICT budget breakdowns in 2013 Description: Synopsis This

More information

PHARMACEUTICAL HUB SWITZERLAND ZURICH-ZUG-LUCERNE

PHARMACEUTICAL HUB SWITZERLAND ZURICH-ZUG-LUCERNE PHARMACEUTICAL HUB SWITZERLAND ZURICH-ZUG-LUCERNE TABLE OF CONTENTS Preface 4 Pharmaceutical Industry in Switzerland 6 Swiss Pharma Clusters 8 Growth Driver Pharmaceuticals 10 Zurich-Zug-Lucerne Region

More information

CORPORATE SPONSORSHIP OPPORTUNITIES 2012

CORPORATE SPONSORSHIP OPPORTUNITIES 2012 LIFE SCIENCE ACADEMY CORPORATE SPONSORSHIP OPPORTUNITIES 2012 th Italian epharma day - Milan, April 19 German epharma day - Frankfurt, April 26 Spanish epharma day - Madrid, October 25 UK epharma day -

More information

List of nationally authorised medicinal products

List of nationally authorised medicinal products 9 July 2015 EMA/483660/2015 Procedure Management and Committees Support Active substance: diphtheria, tetanus, pertussis (acellular, component), poliomyelitis (inactivated), haemophilus type b conjugate

More information

PHARMACEUTICAL INDUSTRY PROFILE

PHARMACEUTICAL INDUSTRY PROFILE PHARMACEUTICAL INDUSTRY PROFILE I. INDUSTRY BACKGROUND A. Industry Definition The U.S. pharmaceutical industry is defined by the Census Bureau as companies engaged in researching, developing, manufacturing,

More information

Clinical Trial Logistics

Clinical Trial Logistics BOOK BY 31ST MARCH TO SAVE 100 SMi presents the 8th conference and exhibition series... Clinical Trial Logistics 21ST - 22ND MAY 2014 MARRIOTT REGENTS PARK LONDON, UK EUROPE'S LEADING CLINICAL TRIAL LOGISTICS

More information

LuxeMbOurG Trading CenT re LisT Annex 1 to the special terms and conditions for securities transactions Valid as from 1 september 2011

LuxeMbOurG Trading CenT re LisT Annex 1 to the special terms and conditions for securities transactions Valid as from 1 september 2011 Luxembourg Annex 1 to the Special terms and conditions for securities transactions Valid as from 1 September 2011 In order to achieve the best possible result in executing security orders, the bank has

More information

e-labeling : innovation for patient or regulation nightmare Pharmapack Feb, 11 th, 2015

e-labeling : innovation for patient or regulation nightmare Pharmapack Feb, 11 th, 2015 e-labeling : innovation for patient or regulation nightmare Pharmapack Feb, 11 th, 2015 PHARMAPACK 2015 1 Mobile health x2 30 months 100 000 mapps Source: research2guidance, mhealth App Market Report 2013-2017

More information

Pharmaceutical industry

Pharmaceutical industry 8 th March 2016 Pharmaceutical industry 2015 Global ranking strategy decisive The annual company reporting season is always an exciting period. It is an ideal time to update our industry statistics and

More information

Main Conference Agenda

Main Conference Agenda Sponsored by: (Co-located with Bioequivalence: Intersection between Science & Regulatory Conference) Main Conference Agenda Day One Wednesday, November 5 th, 2014 7:30 Registration Opens & Continental

More information

The 2015 Avoca Report. Clinical Development Innovation. Sponsor and Provider Views on Innovation in Outsourced Clinical Development

The 2015 Avoca Report. Clinical Development Innovation. Sponsor and Provider Views on Innovation in Outsourced Clinical Development The 2015 Avoca Report Clinical Development Innovation Sponsor and Provider Views on Innovation in Outsourced Clinical Development Contents Section Slides Research Overview 3-5 Respondent Demographics 6-9

More information

3 Year: Year of the submission of the ingredient information.

3 Year: Year of the submission of the ingredient information. 1 2 Footnotes to Table 3 Name of Manufacturer or Importer: This information is submitted by Philip Morris Products S.A., which owns the relevant intellectual property rights of Philip Morris International

More information

Pr. Dominique JOLLY SKEMA BS. Animatrice : Valérie BLANCHOT COURTOIS

Pr. Dominique JOLLY SKEMA BS. Animatrice : Valérie BLANCHOT COURTOIS Cycle Innovation & Connaissance 17 petit déjeuner Vendredi 14 février 2014 Comment les entreprises occidentales parient sur la création technologique en Chine? Du cost-driven au knowledge-driven Pr. Dominique

More information

ERMInE Database. Presentation by Nils Flatabø SINTEF Energy Research. ERMInE Workshop 2 - Northern Europe Oslo, 1. November 2006

ERMInE Database. Presentation by Nils Flatabø SINTEF Energy Research. ERMInE Workshop 2 - Northern Europe Oslo, 1. November 2006 ERMInE Database Presentation by Nils Flatabø SINTEF Energy Research ERMInE Workshop 2 - Northern Europe Oslo, 1. November 26 Overview Content of the Ermine Database Electronic Questionnaire RTD&D Data

More information

Multiple Sclerosis Treatments: World Market Outlook to 2011

Multiple Sclerosis Treatments: World Market Outlook to 2011 Brochure More information from http://www.researchandmarkets.com/reports/2860814/ Multiple Sclerosis Treatments: World Market Outlook to 2011 Description: Multiple sclerosis (MS) is a chronic demyelinating

More information

Dublin, March 2013. EPSO Network of Experts in the field of Personnel Selection 14th March 2013

Dublin, March 2013. EPSO Network of Experts in the field of Personnel Selection 14th March 2013 Dublin, March 2013 EPSO Network of Experts in the field of Personnel Selection 14th March 2013 On-going and upcoming competitions AD2012 by Citizenship AD2012 Citizenship %EU Population validated application

More information

Medical Communication Companies and Industry Grants

Medical Communication Companies and Industry Grants Research Brief Report Communication Companies and Industry Grants Sheila M. Rothman, PhD; Karen F. Brudney, MD; Whitney Adair, BA; David J. Rothman, PhD IMPORTANCE communication companies (MCCs) are among

More information

Brochure More information from http://www.researchandmarkets.com/reports/3292678/

Brochure More information from http://www.researchandmarkets.com/reports/3292678/ Brochure More information from http://www.researchandmarkets.com/reports/3292678/ Asia Pacific (India, China, Australia, South Korea & Others) Insulin Market (Rapid Acting, Short Acting, Pre-Mixed, Long

More information

Mondelēz International entity which issued the PO matches Mondelēz International entity to which you issue your invoice

Mondelēz International entity which issued the PO matches Mondelēz International entity to which you issue your invoice How to get your invoice paid on time? Truth is we want the same thing you do to process your invoices smoothly and pay on time. Reaching this goal requires contribution from all parties involved in ordering

More information

Renewable Energy Certificate systems in Europe (the path to international trade)

Renewable Energy Certificate systems in Europe (the path to international trade) Renewable Energy Certificate systems in Europe (the path to international trade) Marcel Galjee Board member RECS International Athens, March 31 st 2004 Outline of the presentation About RECS RECS International

More information

Pipeline, timeline, deadline

Pipeline, timeline, deadline Pipeline, timeline, deadline Improve your bottom line Life Sciences Building Management Solutions Put your buildings to work for you Keep your product pipeline flowing We ll show you how You re up against

More information

INCENTIVE COMPENSATION CONFERENCE

INCENTIVE COMPENSATION CONFERENCE Announcing the 2nd Annual ZS Associates INCENTIVE COMPENSATION CONFERENCE 08 September 23 24, 2008 Philadelphia, PA Incentive compensation greatly affects sales force motivation and morale. When designed

More information

Project Portfolio. Management. Our Expert. Pre-Conference Workshop 22 nd October 2014. Speaker Panel. 23 24 October 2014 Eurostars Berlin Hotel

Project Portfolio. Management. Our Expert. Pre-Conference Workshop 22 nd October 2014. Speaker Panel. 23 24 October 2014 Eurostars Berlin Hotel visit our website: www.flemingeurope.com Our Expert Speaker Panel Martine Mazzetti AstraZeneca Vice President IMED Project Management Andreas Kirberg STADA Arzneimittel AG Vice President Business Development

More information

How to get your invoice paid on time?

How to get your invoice paid on time? How to get your invoice paid on time? Truth is we want the same thing you do to process your invoices smoothly and pay on time. Moving to OB10 e-invoicing platform enhances our capabilities to reach this

More information